It should be kept in mind that cytokeratin 19 is positive in a variety of adenocarcinomas, including cholangiocarcinoma; therefore, it is used as a prognostic, but not as a diagnostic marker for HCC. This evidence concerns the gene KRT19 and hepatocellular carcinoma.